Caption Management, LLC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1706766 OKLAHOMA CITY, OK

Back to APLS Full portfolio

Position in APLS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

+$0 QoQ

Shares Held

-100.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

22 quarters on record

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Derivatives in APLS

reported options exposure · as of Mar 31, 2026

CallValue

CallShares

63,500

PutValue

PutShares

63,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Caption Management, LLC holds $249,760,911 across 78 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	CGON	CG Oncology, Inc.	484,461	$34,420,954
2	INSM	INSMED Inc	236,000	$25,162,320
3	ERAS	Erasca, Inc.	1,041,225	$19,075,242
4	CELC	Celcuity Inc.	170,000	$17,785,400
5	DSGN	Design Therapeutics, Inc.	1,118,098	$16,178,878
6	MLYS	Mineralys Therapeutics, Inc.	413,087	$11,145,087
7	REPL	Replimune Group, Inc.	783,873	$8,677,474
8	TARS	Tarsus Pharmaceuticals, Inc.	120,700	$7,596,858

All Filings in APLS

Export CSV

50 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	—	63,500	0.0%	Put	Sole	2026-05-15
2026-03-31	—	63,500	-89.5%	Call	Sole	2026-05-15
2025-12-31	—	602,700	+0.4%	Call	Sole	2026-02-17
2025-12-31	—	63,500	-6.3%	Put	Sole	2026-02-17
2025-12-31	—	254,563	-16.5%	Shares	Sole	2026-02-17
2025-09-30	—	305,000	+32.1%	Shares	Sole	2025-11-14
2025-09-30	—	600,400	+16.6%	Call	Sole	2025-11-14
2025-09-30	—	67,800	+126.0%	Put	Sole	2025-11-14
2025-06-30	—	230,888	+1824.1%	Shares	Sole	2025-08-14
2025-06-30	—	515,000	+267.9%	Call	Sole	2025-08-14
2025-03-31	—	30,000	-64.9%	Put	Sole	2025-05-15
2025-03-31	—	140,000	-79.0%	Call	Sole	2025-05-15
2025-03-31	—	12,000	-94.4%	Shares	Sole	2025-05-15
2024-12-31	—	666,800	+13.0%	Call	Sole	2025-02-14
2024-12-31	—	85,500	+42.5%	Put	Sole	2025-02-14
2024-09-30	—	216,006	-49.8%	Shares	Sole	2024-11-14
2024-09-30	—	60,000	-63.4%	Put	Sole	2024-11-14
2024-09-30	—	590,000	-41.3%	Call	Sole	2024-11-14
2024-06-30	—	430,000	+1287.1%	Shares	Sole	2024-08-14
2024-06-30	—	163,900	+173.2%	Put	Sole	2024-08-14
2024-06-30	—	1,004,700	+1574.5%	Call	Sole	2024-08-14
2024-03-31	—	60,000	-82.2%	Call	Sole	2024-05-15
2024-03-31	—	60,000	-74.9%	Put	Sole	2024-05-15
2024-03-31	—	31,000	-92.1%	Shares	Sole	2024-05-15
2023-12-31	—	239,300	-6.2%	Put	Sole	2024-02-14
2023-12-31	—	393,031	+43.8%	Shares	Sole	2024-02-14
2023-12-31	—	336,400	-42.7%	Call	Sole	2024-02-14
2023-09-30	—	255,000	+96.2%	Put	Sole	2023-11-14
2023-09-30	—	587,200	+254.8%	Call	Sole	2023-11-14
2023-09-30	—	273,250	+121886.6%	Shares	Sole	2023-11-14
2023-06-30	—	130,000	-51.9%	Put	Sole	2023-08-14
2023-06-30	—	224	-98.7%	Shares	Sole	2023-08-14
2023-06-30	—	165,500	-69.9%	Call	Sole	2023-08-14
2023-03-31	—	550,500	+1472.9%	Call	Sole	2023-05-15
2023-03-31	—	270,500	+286.4%	Put	Sole	2023-05-15
2022-12-31	—	17,000	-92.3%	Shares	Sole	2023-02-14
2022-12-31	—	70,000	-89.2%	Put	Sole	2023-02-14
2022-12-31	—	35,000	-46.2%	Call	Sole	2023-02-14
2022-09-30	—	65,000	-0.5%	Call	Sole	2022-11-14
2022-03-31	—	65,300	+117.7%	Call	Sole	2022-05-13
2022-03-31	—	648,700	+194.9%	Put	Sole	2022-05-13
2021-12-31	—	220,000	+926.0%	Shares	Sole	2022-02-11
2021-12-31	—	220,000	-62.4%	Put	Sole	2022-02-11
2021-12-31	—	30,000	-94.2%	Call	Sole	2022-02-11
2021-09-30	—	520,900	+181.6%	Call	Sole	2021-11-12
2021-09-30	—	585,300	+216.4%	Put	Sole	2021-11-12
2021-09-30	—	21,443	-69.6%	Shares	Sole	2021-11-12
2021-06-30	—	185,000	—	Put	Sole	2021-08-16
2021-06-30	—	70,500	—	Shares	Sole	2021-08-16
2021-06-30	—	185,000	—	Call	Sole	2021-08-16
No filing history on record for this holder in this stock.